Trial · NCT04590586
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Lanadelumab + Standard of Care | 28 | |
| Overall Study | STARTED | Lanadelumab Placebo + Standard of Care | 1 | |
| Overall Study | STARTED | Apremilast + Standard of Care | 194 | |
| Overall Study | STARTED | Apremilast Placebo + Standard of Care | 184 | |
| Overall Study | STARTED | Zilucoplan + Standard of Care | 100 | |
| Overall Study | STARTED | Zilucoplan Placebo + Standard of Care | 8 | |
| Overall Study | Received Study Drug | Lanadelumab + Standard of Care | 27 | |
| Overall Study | Received Study Drug | Lanadelumab Placebo + Standard of Care | 1 | |
| Overall Study | Received Study Drug | Apremilast + Standard of Care | 189 | |
| Overall Study | Received Study Drug | Apremilast Placebo + Standard of Care | 182 | |
| Overall Study | Received Study Drug | Zilucoplan + Standard of Care | 95 | |
| Overall Study | Received Study Drug | Zilucoplan Placebo + Standard of Care | 7 | |
| Overall Study | Full Analysis Set | Lanadelumab + Standard of Care | 28 | |
| Overall Study | Full Analysis Set | Lanadelumab Placebo + Standard of Care | 34 | |
| Overall Study | Full Analysis Set | Apremilast + Standard of Care | 194 | |
| Overall Study | Full Analysis Set | Apremilast Placebo + Standard of Care | 190 | |
| Overall Study | Full Analysis Set | Zilucoplan + Standard of Care | 100 | |
| Overall Study | Full Analysis Set | Zilucoplan Placebo + Standard of Care | 75 | |
| Overall Study | COMPLETED | Lanadelumab + Standard of Care | 15 | |
| Overall Study | COMPLETED | Lanadelumab Placebo + Standard of Care | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04590586/flow